Arginine Depletion with DFMO in High-Risk Neuroblastoma |
Children’s Hospital of Philadelphia / Christina Turn, MD |
Young Investigator Grants |
2023 |
Pennsylvania |
E2A translocations in pediatric leukemia: developing new therapeutic targets
|
Children’s Hospital of Philadelphia / Bruce Fischer, MD |
Young Investigator Grants |
2007 |
Pennsylvania |
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD |
Young Investigator Grants |
2014 |
Washington |
Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML |
Boston Children’s Hospital / Anne Robertson, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Defining the Molecular Mechanisms Underlying Pediatric Brain Tumor Penetrance |
Washington University / Nicole Brossier, MD/PhD |
Young Investigator Grants |
2019 |
Missouri |
Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children’s Hospital of Philadelphia / Jenny Ruiz, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
DFMO-based combination therapy for the treatment of advanced stage neuroblastoma.
|
Cancer Research Center of Hawaii / Dana-Lynn Koomoa |
Young Investigator Grants |
2009 |
Hawaii |
Targeting the Rac GTPase Pathway to Sabotage RAS Signaling in RAS-mutated Leukemia |
Boston Children’s Hospital / Sara Canovas Nunes, PhD |
Young Investigator Grants |
2020 |
Massachusetts |
A Role for Non-canonical Wnt/PCP Signaling in Growth and Self-Renewal of Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Madeline Hayes, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
Ex Vivo Modeling of Medulloblastoma using Human iPSC-Derived Cerebellar Organoids |
St. Jude Children’s Research Hospital / Stephanie Wu, PhD |
Young Investigator Grants |
2023 |
Tennessee |